NCI at ASCO- Last Chance to Visit NCI's Exhibit Booth

NCI at ASCO 2019 MONDAY, JUNE 3 Thank you for joining NCI as we showcase our research and programs at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting. Today is the last day to visit the NCI exhibit booth, so be sure to stop by!  More information about how NCI is participating at ASCO can also be found on the NCI at ASCO 2019 webpage.

Today's Sessions Featuring NCI Speakers The Impact of Big Data Research on Practice, Policy, and Patient Care Monday, June 3, 8:00 AM - 9:15 AM David Chambers, MSc, DPhil, Deputy Director for Implementation Science in NCI's Division of Cancer Control and Population Sciences will chair this education session and present on "How to Implement and Disseminate Clinical Trial and Big Data Results." The session will include three other speakers as well as a panel Q&A session.  Beyond Checkpoint Blockade: An Update on Engineered T-Cell Therapy and Neoantigen Vaccine Application Monday, June 3, 11:30 AM - 12:45 PM Stephanie L. Goff, MD, Associate Research Physician of NCI's Center for Cancer Research will present on "Tumor Infiltrating Lymphocytes Therapy." This education session follows both the Developmental Immunotherapy and Tumor Immunobiology tracks.  Financial Assistance for Participation in Clinical Trials: What Works Best for Patients? Monday, June 3, 4:45 PM - 5:45 PM Sheila Ann Prindiville, MD, MPH, Director of NCI's Coordinating Center for Clinical Trials is presenting on "NAVIGATE Program: The National Cancer Institute/Veterans Affairs Approach to Recruiting Patients to Clinical Trials." This interactive case-base session follows: Health Services Research, Clinical Informatics, and Quality of Care, Care Delivery and Practice Management, Clinical Trials, and Disparities/Health Equity tracks. Tomorrow's Sessions Featuring NCI Speakers The Who, What, and Where of CAR T Tuesday, June 4, 8:00 AM - 9:30 AM This clinical science symposium will be chaired by James L. Gulley, MD, PhD, FACP, Chief of the Genitourinary Malignancies Branch in NCI's Center for Cancer Research, and will include six sessions, as well as a panel Q&A.  Point/Counterpoint: Duration of Therapy in Indolent Lymphoma and Chronic Lymphocytic Leukemia Tuesday, June 4, 8:00 AM - 9:15 AM Mark J. Roschewski, MD, Senior Clinician of the Lymphoid Malignancies Branch in NCI's Center for Cancer Research will present on "No Maintenance Required: Arguing in Favor of Observation after Frontline Therapy in Follicular Lymphoma." This education session follows both Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia tracks. Visit the NCI Exhibit (#4075) Want to learn more about what's happening across the National Cancer Institute? Visit the NCI Exhibit from Saturday, June 1- Monday June 3 to speak with staff, learn about NCI programs and initiatives at interactive kiosks, pick up free publications, and more!  We look forward to seeing you there.